CRISPR-Cas-Based Platform for Single-Step Quantification of Monoclonal Antibodies at Point-of-Care
ACS Sensors · 24.07.2026 · 11 (7) · 5515-5524
DOI: 10.1021/acssensors.5c04532 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 30.06.2026. Verfasst von Stefano Del Giovane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Center for Electronics and Microtechnology (CSEM), Landquart7302, Switzerland. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, CRISPR-Cas Systems, Point-of-Care Systems. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, HORIZON EUROPE European Innovation Council, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
We report a streamlined, cost-effective point-of-care platform for the quantitative detection of monoclonal antibodies for therapeutic drug monitoring, addressing the limitations of bulky, complex, and expensive instrumentation required for standard analytical techniques. In contrast to conventional immunoassays that rely on primary/secondary antibodies for quantification, our method leverages a DNA circuit for the recognition of the target monoclonal antibody coupled with CRISPR-Cas12a signal amplification. This assay is integrated into a microfluidic chip that enables a single-step workflow, eliminating the multiple incubations and reagent addition steps typical of laboratory methods. The platform demonstrates quantitative detection of a model anti-hemagglutinin antibody within a 60-min sample-to-answer timeframe, in the nanomolar range, with a chip manufacturing cost below 1€ and reagent stability confirmed at –20 °C for over one month. This proof-of-concept illustrates the potential of simplified CRISPR-based assays for decentralized rapid protein quantification in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Swiss Center for Electronics and Microtechnology (CSEM), Landquart7302, Switzerland.
- Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne1015, Switzerland.
- Department of Sciences and Chemical Technologies, University of Rome Tor Vergata, Rome00133, Italy.
ORCID-Profile: Stefano Del Giovane, Hatice Altug
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- HORIZON EUROPE European Innovation Council
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Staatssekretariat für Bildung, Forschung und Innovation
Zitieren
APA
Del Giovane, S., Migliorelli, D., Paoletti, S., Bagheri, N., Altug, H., & Burr, L. (2026). CRISPR-Cas-Based Platform for Single-Step Quantification of Monoclonal Antibodies at Point-of-Care. ACS Sensors, 11(7), 5515-5524. https://doi.org/10.1021/acssensors.5c04532
Vancouver
Del Giovane S, Migliorelli D, Paoletti S, Bagheri N, Altug H, Burr L. CRISPR-Cas-Based Platform for Single-Step Quantification of Monoclonal Antibodies at Point-of-Care. ACS Sensors. 2026;11(7):5515-5524. doi:10.1021/acssensors.5c04532
BibTeX
@article{DelGiovane2026,
author = {Del Giovane, Stefano and Migliorelli, Davide and Paoletti, Samantha and Bagheri, Neda and Altug, Hatice and Burr, Loïc},
title = {CRISPR-Cas-Based Platform for Single-Step Quantification of Monoclonal Antibodies at Point-of-Care},
journal = {ACS Sensors},
year = {2026},
volume = {11},
number = {7},
pages = {5515--5524},
doi = {10.1021/acssensors.5c04532}
}
EUVIMED